Literature DB >> 28916478

A retrospective study of pulseless electrical activity, bedside ultrasound identifies interventions during resuscitation associated with improved survival to hospital admission. A REASON Study.

Romolo Gaspari1, Anthony Weekes2, Srikar Adhikari3, Vicki Noble4, Jason T Nomura5, Daniel Theodoro6, Michael Woo7, Paul Atkinson8, David Blehar9, Samuel Brown10, Terrell Caffery11, Emily Douglass4, Jacqueline Fraser12, Christine Haines13, Samuel Lam14, Michael Lanspa10, Margaret Lewis2, Otto Liebmann15, Alexander Limkakeng16, Fernando Lopez16, Elke Platz17, Michelle Mendoza9, Hal Minnigan18, Christopher Moore19, Joseph Novik20, Louise Rang21, Will Scruggs22, Christopher Raio13.   

Abstract

OBJECTIVE: Our objective was to determine whether organized or disorganized cardiac activity is associated with increased survival in patients who present in pulseless electrical activity (PEA) treated with either 1) standard advanced cardiac life support (ACLS) medications or 2) other interventions.
METHODS: This was a secondary analysis of a prospective, multi-center observational study utilizing ultrasound in out-of-hospital or inemergency department PEA arrest. Bedside ultrasound was performed as ACLS protocol started and during pulse checks. Only cases with visible cardiac activity on ultrasound were included in the present analysis. Cardiac activity was categorized as disorganized (agonal twitching) or organized (contractions with changes in ventricular dimensions). Patients were categorized as receiving either standard bolus ACLS medications or alternative medications during the resuscitation (continuous adrenergic agents, thrombolytics, others). The primary outcome was survival to hospital admission. The secondary outcome was return of spontaneous circulation (ROSC). Multivariate modeling was performed to assess association between survival to hospital admission in patients with intravenous adrenergic agents and cardiac activity.
RESULTS: In our cohort of 225 patients in PEA cardiac arrest with cardiac activity on ultrasound, the overall survival rate was higher in patients with organized cardiac activity than with disorganized cardiac activity. PEA cardiac arrest patients with organized cardiac activity treated with standard ACLS interventions demonstrated improved survival to hospital admission compared to those with disorganized activity (37.7% (95%CI 24.8-50.2%) versus 17.9% (95%CI 10.9-28%). PEA cardiac arrest patients with organized cardiac activity who received continuous adrenergic agents during the resuscitation and prior to ROSC demonstrated higher survival to hospital admission 45.5% (95%CI 26.9-65.4%) and ROSC 90.9% (95%CI 71.0-98.7%) compared to those with disorganized cardiac activity who received continuous adrenergic agents during the resuscitation 0% (95%CI 0-23.0%) and 47.1% (95%CI 26-69%). Regression analysis demonstrates an association between increased survival in patients receiving intravenous adrenergic agents and organized cardiac activity.
CONCLUSION: Survival in patients following PEA arrest is higher in patients with organized cardiac activity. The initiation of continuous adrenergic agents during PEA was associated with improved survival to hospital admission in patients with organized cardiac activity on bedside ultrasound, but this improvement was not seen in patients in PEA with disorganized cardiac activity. Bedside ultrasound may identify a subset of patients that respond differently to ACLS interventions.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bedside ultrasound; Cardiac arrest; Point-of-care ultrasound; Pulseless electrical activity; Ultrasound

Mesh:

Substances:

Year:  2017        PMID: 28916478     DOI: 10.1016/j.resuscitation.2017.09.008

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  8 in total

Review 1.  In-hospital cardiac arrest: are we overlooking a key distinction?

Authors:  Ari Moskowitz; Mathias J Holmberg; Michael W Donnino; Katherine M Berg
Journal:  Curr Opin Crit Care       Date:  2018-06       Impact factor: 3.687

2.  Utilization of Point-of-care Echocardiography in Cardiac Arrest: A Cross-sectional Pilot Study.

Authors:  Yanika Wolfe; YouYou Duanmu; Viveta Lobo; Michael A Kohn; Kenton L Anderson
Journal:  West J Emerg Med       Date:  2021-07-20

3.  Sudden cardiac arrest and ventricular arrhythmias following first type I myocardial infarction in the contemporary era.

Authors:  Mustapha Amin; Danesh Kella; Ammar M Killu; Deepak Padmanabhan; David O Hodge; Michael A Golafshar; Alanna M Chamberlain; Justin Z Lee; Win-Kuang Shen; Paul A Friedman; Samuel J Asirvatham; Véronique L Roger; Bernard J Gersh; Siva K Mulpuru
Journal:  J Cardiovasc Electrophysiol       Date:  2019-10-17

Review 4.  A Systemic Review on the Diagnostic Accuracy of Point-of-Care Ultrasound in Patients With Undifferentiated Shock in the Emergency Department.

Authors:  Ingvar Berg; Kris Walpot; Hein Lamprecht; Maxime Valois; Jean-François Lanctôt; Nadim Srour; Crispijn van den Brand
Journal:  Cureus       Date:  2022-03-15

5.  Cardiac Tamponade: A Case for Point-of-Care Ultrasound.

Authors:  Ronald H Wharton; Steven A Greenstein
Journal:  CASE (Phila)       Date:  2022-08-15

6.  Development and validation of a novel image quality rating scale for echocardiography during cardiac arrest.

Authors:  Romolo Gaspari; Felipe Teran; Andrew Kamilaris; Timothy Gleeson
Journal:  Resusc Plus       Date:  2021-03-06

7.  Echocardiographic pre-pause imaging and identifying the acoustic window during CPR reduces CPR pause time during ACLS - A prospective Cohort Study.

Authors:  Romolo Gaspari; Justin Harvey; Christopher DiCroce; Ari Nalbandian; Michael Hill; Robert Lindsay; Alexandra Nordberg; Powell Graham; Andrew Kamilaris; Timothy Gleeson
Journal:  Resusc Plus       Date:  2021-03-06

8.  Epinephrine plus chest compressions is superior to epinephrine alone in a hypoxia-induced porcine model of pseudo-pulseless electrical activity.

Authors:  Felipe Teran; Claire Centeno; Alexander L Lindqwister; William J Hunckler; William P Landis; Karen L Moodie; Frances S Shofer; Benjamin S Abella; Norman A Paradis
Journal:  Resusc Plus       Date:  2021-04-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.